Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new research and biomanufacturing capacity for Canada.
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH) and/or other pan-Canadian health organizations.
Implementation of the Biomanufacturing and Life Sciences Strategy by ISED and Health Canada.
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
Regulation
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.